Icon (ICLR) Total Liabilities (2009 - 2026)
Icon's (ICLR) quarterly Total Liabilities came in at $7.0 billion in Q2 2026, little changed year-over-year from $7.0 billion in Q2 2025, and little changed quarter-over-quarter from $7.0 billion in Q1 2026.
Analysis
Icon (ICLR) Total Liabilities (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Total Liabilities for 18 consecutive years, with $7.0 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Liabilities changed 0.36% year-over-year to $7.0 billion in Q2 2026; TTM through Jun 2026 was $7.0 billion, a 0.36% change from a year earlier, with the FY2025 full-year figure at $7.1 billion, down 1.61% from the prior year.
- Total Liabilities was $7.0 billion for Q2 2026 at Icon, roughly flat from $7.0 billion in the prior quarter.
- Over five years, Total Liabilities peaked at $12.1 billion in Q1 2024 and troughed at $7.0 billion in Q1 2026.
- A 5-year average of $8.0 billion and a median of $7.5 billion in 2023 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities surged 471.17% in 2022 and sank 40.29% in 2025, its largest moves.
- Over 5 years, Total Liabilities stood at $8.7 billion in 2022, then dropped by 11.9% to $7.7 billion in 2023, then retreated by 6.02% to $7.2 billion in 2024, then slipped by 1.61% to $7.1 billion in 2025, then decreased by 0.77% to $7.0 billion in 2026.
- The last three Total Liabilities figures came in at $7.0 billion (Q2 2026), $7.0 billion (Q1 2026), and $7.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 23.58 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.62 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 7.02 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 4.64 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.19 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.06 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 569.76 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 28.83 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 7.47 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 6.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.02 Bn |
| Mar 31, 2026 | 7.02 Bn |
| Dec 31, 2025 | 7.08 Bn |
| Sep 30, 2025 | 7.17 Bn |
| Jun 30, 2025 | 7.05 Bn |
| Mar 31, 2025 | 7.22 Bn |
| Dec 31, 2024 | 7.19 Bn |
| Sep 30, 2024 | 7.44 Bn |
| Jun 30, 2024 | 7.38 Bn |
| Mar 31, 2024 | 12.09 Bn |
| Dec 31, 2023 | 7.65 Bn |
| Sep 30, 2023 | 8.07 Bn |
| Jun 30, 2023 | 8.31 Bn |
| Mar 31, 2023 | 8.63 Bn |
| Dec 31, 2022 | 8.69 Bn |
| Sep 30, 2022 | 8.89 Bn |
| Jun 30, 2022 | 8.89 Bn |
| Mar 31, 2022 | 9.09 Bn |
| Dec 31, 2021 | 9.31 Bn |
| Sep 30, 2021 | 9.69 Bn |